The SCIENCE
The science of obesity is moving at an incredible pace. Every day more research is published on obesity from multiple areas of the scientific community. More information than ever points towards obesity as being a chronic, relapsing, biologically and environmentally driven disease that is not within the control of the individual.
Neuroscience, genetics, epigenetics, and the environment all have a part to play, according to emerging research.
Scroll down to learn more about the recent scientific findings on four factors that play a role in driving obesity and how research projects like SOPHIA are focused on personalised treatments for patients.
Prof Bart Van der Scheuren MD, PhD: The Science of Obesity
The Weight Set Point/Set Range Theory
The body naturally tends to maintain a stable weight within a limited range, even without us consciously controlling it. This weight range, also known as the body’s set point, is not within our conscious control. This set point is what the body decides is the safest for its survival, and it will resist deviations away from this through various mechanisms, including hormone signaling and brain chemistry.
For people living with obesity, losing weight is very challenging, and keeping weight off is even more difficult as the weight that the body has set may be higher for them. Through many complex processes, their body works hard to defend that weight. Understanding that obesity is a disease and not the individual’s fault is extremely important.
Things that can affect the set point include our genes, changes in our genes in response to our environment, certain illnesses, stress, some pharmaceuticals or medicines and bariatric surgery.
For more information, see:
Dr Andrew JENKINSON: The Weight set point
Metabolic Adaptation
Metabolic Adaptation is the body’s physiological response to calorie restriction. It will slow metabolism to conserve energy and defend the weight set point. This adaptive process is crucial for survival in times of food scarcity, as it ensures that the body doesn’t expend more energy than it can acquire. However, our modern environments and dieting can create metabolic adaptations that make it much harder to lose weight. When we severely restrict calories, our bodies perceive this as threatening our energy balance. As a result, they trigger mechanisms to conserve energy and minimize the rate at which calories are burned. These changes are made via hormonal changes, body temperature regulation, and overall energy expenditure changes.
These compensatory mechanisms, while helpful in a survival context, can hinder weight loss and maintenance efforts in modern society. The body’s set point weight tends to resist significant changes, making it challenging to lose and keep weight off through restrictive diets alone.
For more information, see:
Leptin Resistance
Leptin is a hormone produced by fat cells that acts like a messenger from your body to your brain. It communicates how much fat you have stored and helps regulate your appetite, energy expenditure, and how much energy the body wants to burn.
When it works correctly, leptin signals the brain to make us less hungry and increase energy expenditure, helping us maintain a stable body weight. However, in people living with obesity, the leptin signal can become “blocked” or “not seen” by the brain. This is called leptin resistance. Several things can contribute to leptin resistance over time, including inflammation, high insulin or insulin resistance, and genetic predisposition. When leptin resistance occurs, the brain doesn’t receive a clear message from the fat cells that there is enough stored energy, which can lead to a persistent feeling of hunger and a lower metabolic rate.
As a result, some people living with obesity may feel continually hungry but also have difficulty burning energy, even though their bodies may have enough stored fat, have accumulated excessive fat. This can lead to further weight gain and the development of obesity-related complications.
For more information, see:
ULTRA PROCESSED FOOD
Energy Intake, our Modern Food Environment and Ultra Processed Foods.
Our modern food environment, and particularly ultra-processed foods (UPFs) are increasingly being linked to rising levels of obesity.
What are ultra-processed foods (UPFs)?
UPFs come in many forms and are widely found in our modern food environment. Ways to spot them include long lists of ingredients that wouldn’t be used in a domestic kitchen or a long shelf-life.
It is important to note:
- Not all UPFs are created equal: Some UPFs may be healthier than others depending on their ingredients and overall nutritional profile.
- Other factors play a role: UPF consumption is just one factor contributing to obesity, and additional factors such as individual biology, genetics, and overall dietary patterns also play important roles.
Why are UPFs a concern?
- They are created to be highly palatable: UPFs are often engineered to be extremely tasty and addictive, using flavourings, textures, and macronutrient combinations that trigger the reward centres in the brain.
- This “hyper-palatability” can interact with our ancient evolutionary appetite and motivation systems to generate over-consumption.
- They are often packaged with misleading health claims or portion sizes.
- Research, investigating the specific mechanisms by which UPFs influence energy intake, includes effects on appetite hormones, gut bacteria, and reward pathways, is a relatively recent area of study.
- The long-term effects of these foods on people more prone to obesity (via their specific genetic makeup) are not yet known.
- The body has metabolic and hedonic regulatory systems for maintaining our weight “set-point” and overexposure to UPFs can override these systems’ homeostasis (balance).
The latest science
Among some of the latest peer-reviewed scientific research that suggests a link between the consumption of ultra-processed foods and obesity are:
A systematic review in the Nutrition Journal analysed 20 epidemiological studies on the health outcomes associated with ultra-processed food consumption. This review included over 334,000 participants and found a significant association between the consumption of ultra-processed foods and an increased risk of overweight and obesity, among other health outcomes.
Research published in the European Journal of Clinical Nutrition also supports the link between ultra-processed food consumption and obesity. This includes studies conducted in Iran, Canada, Brazil, the United States, and several European countries, which have consistently demonstrated a strong association between high consumption of ultra-processed foods and increased obesity indicators.
For more information, see:
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053237/
- https://royalsocietypublishing.org/doi/10.1098/rstb.2022.0449#d1e1215
- Chen, X., Zhang, Z., Yang, H. et al. Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies. Nutr J 19, 86 (2020). https://doi.org/10.1186/s12937-020-00604-1
- Harb, A. A., Shechter, A., & Koch, P. A. (2023). Ultra-processed foods and the development of obesity in adults. European Journal of Clinical Nutrition, 77(6), 619-627. https://doi.org/10.1038/s41430-022-01225-z
- Chang, K., Gunter, M., et al. (2023). Ultra-processed food consumption, cancer risk and cancer mortality: a large-scale prospective analysis within the UK Biobank. https://doi.org/10.1016/j.eclinm.2023.101840
- van Galen, K.A., Schrantee, A., ter Horst, K.W. et al. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study. Nat Metab 5, 1059–1072 (2023). https://doi.org/10.1038/s42255-023-00816-9
EMERGING SCIENCE
Project SOPHIA
SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy) is a €16 million EU and industry-supported international research project to develop usable tools to predict who will develop complications of obesity.
Obesity is associated with more than 200 complications, but we cannot yet predict who will develop them or be affected. Moreover, there are no predictors for who will respond to obesity treatments.
SOPHIA will identify and characterise clinically-meaningful subpopulations of patients with obesity ensuring the use of the right treatment for the right people at the right time. The research consortium will use this knowledge to provide a model for how the world talks about obesity, focused on new understandings and a new vocabulary.
The voices of people living with obesity are at the heart of SOPHIA through a Patient Advisory Board, ensuring that patients’ insights, opinions and wishes are comprehensively included in the study. The research group will contribute to a more patient-centric and equitable narrative around obesity and its multiple impacts on individuals from both a social and medical perspective. It all starts with obesity being a chronic disease, not something people choose to live with.
The end date of the study is May 2025
Project SOPHIA Factsheet (https://www.imi.europa.eu/projects-results/project-factsheets/sophia)
Project website (https://imisophia.eu)
“Obesity Care and Weight Loss are not the same.”
International Obesity Collaborative